Related Experiment Video
Updated: Jun 27, 2026
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Postmenopausal hormone therapy and incident urinary incontinence in middle-aged women
Mary K Townsend1, Gary C Curhan, Neil M Resnick
1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. mary.townsend@channing.harvard.edu
Objective:
The objective of the study was to examine the association of hormone therapy with incident urinary incontinence (UI) in postmenopausal women aged 37-54 years in the Nurses' Health Study II.
Study Design:
Participants reported use of hormone therapy, including hormone type, on biennial questionnaires from 1989 to 2001. Among 7341 postmenopausal women reporting no UI in 2001, we identified 1026 women who developed UI at least monthly between 2001 and 2003. Multivariable logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
Results:
Women currently using hormone therapy had 1.39-fold (95% CI, 1.16-1.67) increased odds of incident UI, compared with women who never used hormone therapy. ORs were similar in current users of oral estrogen alone (OR, 1.35, 95% CI, 1.03-1.78) and oral estrogen with progestin (OR, 1.37, 95% CI, 1.13-1.67).
Conclusion:
These findings suggest an increased risk of UI associated with use of postmenopausal hormone therapy in younger postmenopausal women.
Related Concept Videos
01:28Menopause
01:21Nursing Assessment of the Genitourinary System I: Health History
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
01:25Urinary Tract Infection II: Pathophysiology
01:17Urinary Tract Infection IV: Nursing Management